Literature DB >> 2568654

Influence of the D-2 dopamine receptor agonist quinpirole on the odor detection performance of rats before and after spiperone administration.

R L Doty1, J M Risser.   

Abstract

The influence of five doses of the D-2 receptor agonist quinpirole (0.025, 0.05, 0.075, 0.10, and 0.20 mg/kg IP) on the odor detection performance of 21 adult male Long Evans rats was assessed using high precision olfactometry and a go/no-go operant task. Additionally, ten rats were pre-treated with the D-2 receptor antagonist spiperone (0.62 mg/kg IP) and their performance monitored following quinpirole administration. Treatments were administered every third day in a counterbalanced order, with the quinpirole injections occurring 15 min before, and the spiperone injections 35 min before, the 260-trial test sessions. Quinpirole injection resulted in a dose-dependent decrease in odor detection performance, as measured by the percentage of correct trials and by the non-parametric signal detection sensitivity index SI. Prior treatment with spiperone eliminated these effects. Dose-related influences of quinpirole on (a) the average latency to initiate a detection response (i.e., the S + response latency), (b) the total session duration, and (c) the number of aborted trials were also eliminated or greatly attenuated by prior spiperone injection. These results suggest that D-2 receptors may be involved in the modulation of odor detection performance and related behaviors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568654     DOI: 10.1007/BF00451680

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  11 in total

1.  The effect of drugs on arousal responses produced by electrical stimulation of the reticular formation of the brain.

Authors:  P B BRADLEY; B J KEY
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1958-02

2.  Odor detection performance of rats following d-amphetamine treatment: a signal detection analysis.

Authors:  R L Doty; M Ferguson-Segall
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH23390.

Authors:  S Hjorth; A Carlsson
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

4.  D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects.

Authors:  J R Walters; D A Bergstrom; J H Carlson; T N Chase; A R Braun
Journal:  Science       Date:  1987-05-08       Impact factor: 47.728

5.  Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.

Authors:  A R Braun; P Barone; T N Chase
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

6.  Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor.

Authors:  K Tsuruta; E A Frey; C W Grewe; T E Cote; R L Eskay; J W Kebabian
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

7.  Effects of D- and L-amphetamine on dopamine metabolism and ascorbic acid levels in nucleus accumbens and olfactory tubercle as studied by in vivo differential pulse voltammetry.

Authors:  A Louilot; F Gonon; M Buda; H Simon; M Le Moal; J F Pujol
Journal:  Brain Res       Date:  1985-06-17       Impact factor: 3.252

8.  Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.

Authors:  J Arnt
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

9.  Effects of intrabulbar injections of 6-hydroxydopamine on ethyl acetate odor detection in castrate and non-castrate male rats.

Authors:  R L Doty; M Ferguson-Segall; I Lucki; M Kreider
Journal:  Brain Res       Date:  1988-03-15       Impact factor: 3.252

10.  Gustatory reaction time to various sweeteners in human adults.

Authors:  T Yamamoto; T Kato; R Matsuo; Y Kawamura; M Yoshida
Journal:  Physiol Behav       Date:  1985-09
View more
  29 in total

1.  Effects of the val(158)met catechol-O-methyltransferase gene polymorphism on olfactory processing in schizophrenia.

Authors:  Vidyulata Kamath; Paul J Moberg; Raquel E Gur; Richard L Doty; Bruce I Turetsky
Journal:  Behav Neurosci       Date:  2011-12-12       Impact factor: 1.912

2.  A method for the rapid automated assessment of olfactory function.

Authors:  Steven L Youngentob
Journal:  Chem Senses       Date:  2005-03-01       Impact factor: 3.160

3.  Functional properties of dopaminergic neurones in the mouse olfactory bulb.

Authors:  Angela Pignatelli; Kazuto Kobayashi; Hideyuki Okano; Ottorino Belluzzi
Journal:  J Physiol       Date:  2005-02-24       Impact factor: 5.182

4.  A cross-sectional study contrasting olfactory function in autonomic disorders.

Authors:  E M Garland; S R Raj; A C Peltier; D Robertson; I Biaggioni
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

5.  The D2 antagonist spiperone mimics the effects of olfactory deprivation on mitral/tufted cell odor response patterns.

Authors:  D A Wilson; R M Sullivan
Journal:  J Neurosci       Date:  1995-08       Impact factor: 6.167

6.  Meta-analysis of olfactory function in schizophrenia, first-degree family members, and youths at-risk for psychosis.

Authors:  Paul J Moberg; Vidyulata Kamath; Dana M Marchetto; Monica E Calkins; Richard L Doty; Chang-Gyu Hahn; Karin E Borgmann-Winter; Christian G Kohler; Raquel E Gur; Bruce I Turetsky
Journal:  Schizophr Bull       Date:  2013-05-02       Impact factor: 9.306

Review 7.  Chronic MPTP administration regimen in monkeys: a model of dopaminergic and non-dopaminergic cell loss in Parkinson's disease.

Authors:  Gunasingh J Masilamoni; Yoland Smith
Journal:  J Neural Transm (Vienna)       Date:  2017-08-31       Impact factor: 3.575

8.  Effects of dopamine and fluphenazine on field potential amplitude in the salamander olfactory bulb.

Authors:  M R Gurski; K A Hamilton
Journal:  Exp Brain Res       Date:  1996-03       Impact factor: 1.972

Review 9.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

10.  Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Argelia Esperanza Rojas-Mayorquin; Claudia P Figueiredo; Filipe C Matheus; Laure Ginestet; Caroline Chevarin; Elaine Del Bel; Raymond Mongeau; Michel Hamon; Laurence Lanfumey; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2009-07-21       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.